About Etelcalcetide Hydrochloride
Class: | Calcimimetic agent
Use: | Treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis
Adult dose: | Initial dose of 5 mg administered intravenously three times per week at the end of dialysis; may be adjusted based on parathyroid hormone (PTH) levels
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Nausea, vomiting, diarrhea, hypocalcemia, muscle spasms, and paresthesia
Contraindications: | Hyp
Drug Class
Calcimimetic agent
Uses & Indications
Treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: Amgen Europe B.V., NETHERLANDS
Package Size
1ml vial x 6
Price & Supplier
Price in UAE: AED 761.50
Dosage Information
Adult Dose
Initial dose of 5 mg administered intravenously three times per week at the end of dialysis; may be adjusted based on parathyroid hormone (PTH) levels
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Nausea, vomiting, diarrhea, hypocalcemia, muscle spasms, and paresthesia
Contraindications & Precautions
Hypocalcemia, hypersensitivity to etelcalcetide or any component of the formulation
Important Warnings
Monitor calcium levels regularly; risk of severe hypocalcemia; caution in patients with a history of seizures or those taking medications that can lower calcium levels
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.